In our study, we identified a role for PHKG2 in radiosensitivity and prognosis of NSCLC by predicting high-throughput transcriptome sequencing and validating radiotherapy-sensitive tissues/cells. Here, PHKG2 is linked to non-small cell lung carcinoma.